• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

急性冠状动脉综合征患者的住院死亡率：前瞻性队列研究中，通过 D-二聚体调整 GRACE 评分可更准确地预测。

Hospital mortality in acute coronary syndrome: adjustment of GRACE score by D-dimer enables a more accurate prediction in a prospective cohort study.

机构信息

Department of Cardiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning, People's Republic of China.

出版信息

BMC Cardiovasc Disord. 2019 Nov 10;19(1):252. doi: 10.1186/s12872-019-1239-4.

DOI:10.1186/s12872-019-1239-4
PMID:31707974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6842504/
Abstract

BACKGROUD

To assess the value of D-dimer and its combination with The Global Registry of Acute Coronary Events (GRACE) score in predicting in-hospital mortality in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI).

METHODS

In 5923 ACS patients undergoing PCI, the role of D-dimer and the added value of D-dimer to GRACE score for predicting in-hospital mortality were tested.

RESULTS

After multivariable adjustment, D-dimer could significantly predict in-hospital mortality. Also, it could significantly improve the prognostic performance of GRACE score (C-statistic: z = 2.269, p = 0.023; IDI: 0.016, p = 0.032; NRI: 0.291, p = 0.035).

CONCLUSION

In patients with ACS undergoing PCI, D-dimer was an independent predictor of in-hospital death. It could also improve the prognostic performance of GRACE score.

摘要

背景

评估 D-二聚体及其与全球急性冠状动脉事件注册（GRACE）评分联合用于预测行经皮冠状动脉介入治疗（PCI）的急性冠状动脉综合征（ACS）患者住院死亡率的价值。

方法

在 5923 例行 PCI 的 ACS 患者中，测试 D-二聚体的作用以及 D-二聚体对 GRACE 评分预测住院死亡率的附加价值。

结果

经多变量调整后，D-二聚体可显著预测住院死亡率。此外，它还可显著改善 GRACE 评分的预后性能（C 统计量：z=2.269，p=0.023；IDI：0.016，p=0.032；NRI：0.291，p=0.035）。

结论

在接受 PCI 的 ACS 患者中，D-二聚体是住院死亡的独立预测因子。它还可以改善 GRACE 评分的预后性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b43/6842504/4f6cad103875/12872_2019_1239_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b43/6842504/8255b91cbbcf/12872_2019_1239_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b43/6842504/4f6cad103875/12872_2019_1239_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b43/6842504/8255b91cbbcf/12872_2019_1239_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b43/6842504/4f6cad103875/12872_2019_1239_Fig2_HTML.jpg

相似文献

1
Hospital mortality in acute coronary syndrome: adjustment of GRACE score by D-dimer enables a more accurate prediction in a prospective cohort study.急性冠状动脉综合征患者的住院死亡率：前瞻性队列研究中，通过 D-二聚体调整 GRACE 评分可更准确地预测。
BMC Cardiovasc Disord. 2019 Nov 10;19(1):252. doi: 10.1186/s12872-019-1239-4.
2
Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.通过糖化血红蛋白调整GRACE评分能够更准确地预测接受经皮冠状动脉介入治疗的非糖尿病急性冠状动脉综合征患者的长期主要不良心脏事件。
Cardiovasc Diabetol. 2015 Aug 19;14:110. doi: 10.1186/s12933-015-0274-4.
3
Value of the fT3/fT4 ratio and its combination with the GRACE risk score in predicting the prognosis in euthyroid patients with acute myocardial infarction undergoing percutaneous coronary intervention: a prospective cohort study.游离三碘甲状腺原氨酸/游离甲状腺素比值及其与GRACE风险评分联合预测接受经皮冠状动脉介入治疗的甲状腺功能正常急性心肌梗死患者预后的价值：一项前瞻性队列研究
BMC Cardiovasc Disord. 2018 Sep 10;18(1):181. doi: 10.1186/s12872-018-0916-z.
4
Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.三酰甘油葡萄糖指数对 GRACE 评分的校正可改善行经皮冠状动脉介入治疗的急性冠状动脉综合征患者临床结局的预测。
Cardiovasc Diabetol. 2022 Aug 5;21(1):145. doi: 10.1186/s12933-022-01582-w.
5
Prognostic impact of alkaline phosphatase for in-hospital mortality in patients with acute coronary syndrome: a prospective cohort study in China.碱性磷酸酶对中国急性冠状动脉综合征患者住院死亡率的预后影响：一项前瞻性队列研究。
BMJ Open. 2019 Aug 8;9(8):e025648. doi: 10.1136/bmjopen-2018-025648.
6
Admission Serum Calcium Levels Improve the GRACE Risk Score Prediction of Hospital Mortality in Patients With Acute Coronary Syndrome.入院时血清钙水平可改善急性冠状动脉综合征患者医院死亡的GRACE风险评分预测。
Clin Cardiol. 2016 Sep;39(9):516-23. doi: 10.1002/clc.22557. Epub 2016 Jun 9.
7
Combined effect of inflammation and malnutrition for long-term prognosis in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a cohort study.炎症和营养不良对行经皮冠状动脉介入治疗的急性冠状动脉综合征患者长期预后的联合影响：一项队列研究。
BMC Cardiovasc Disord. 2024 Jun 17;24(1):306. doi: 10.1186/s12872-024-03951-7.
8
Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada.加拿大急性冠状动脉综合征患者住院死亡率的全球急性冠状动脉事件注册研究（GRACE）风险评分的验证
Am Heart J. 2009 Sep;158(3):392-9. doi: 10.1016/j.ahj.2009.06.010.
9
Combination of the CYP2C19 metabolizer and the GRACE risk score better predicts the long-term major adverse cardiac events in acute coronary syndrome undergoing percutaneous coronary intervention.CYP2C19 代谢酶和 GRACE 风险评分的联合预测可更好地预测行经皮冠状动脉介入治疗的急性冠脉综合征患者的长期主要不良心脏事件。
Thromb Res. 2018 Oct;170:142-147. doi: 10.1016/j.thromres.2018.08.016. Epub 2018 Aug 24.
10
Treatment and outcomes of patients with suspected acute coronary syndromes in relation to initial diagnostic impressions (insights from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]).疑似急性冠状动脉综合征患者的治疗和转归与初始诊断印象的关系（来自加拿大急性冠状动脉事件全球登记处[GRACE]和加拿大急性冠状动脉事件登记处[CANRACE]的见解）。
Am J Cardiol. 2013 Jan 15;111(2):202-7. doi: 10.1016/j.amjcard.2012.09.018. Epub 2012 Nov 1.

引用本文的文献

1
Use of machine learning models to predict in-hospital mortality in patients with acute coronary syndrome.使用机器学习模型预测急性冠状动脉综合征患者的院内死亡率。
Clin Cardiol. 2023 Feb;46(2):184-194. doi: 10.1002/clc.23957. Epub 2022 Dec 7.
2
Prognostic Value of Age-Adjusted D-Dimer Cutoff Thresholds in Patients with Acute Coronary Syndrome Treated by Percutaneous Coronary Intervention.年龄调整 D-二聚体截断值在经皮冠状动脉介入治疗急性冠状动脉综合征患者中的预后价值。
Clin Interv Aging. 2022 Feb 9;17:117-128. doi: 10.2147/CIA.S347168. eCollection 2022.
3
Development of a nomogram for the prediction of in-hospital mortality in patients with acute ST-elevation myocardial infarction after primary percutaneous coronary intervention: a multicentre, retrospective, observational study in Hebei province, China.

本文引用的文献

1
D-Dimer Predicts Long-Term Cause-Specific Mortality, Cardiovascular Events, and Cancer in Patients With Stable Coronary Heart Disease: LIPID Study.D-二聚体可预测稳定型冠心病患者的长期病因特异性死亡率、心血管事件和癌症：LIPID 研究。
Circulation. 2018 Aug 14;138(7):712-723. doi: 10.1161/CIRCULATIONAHA.117.029901.
2
Association of D-dimer with Plaque Characteristics and Plasma Biomarkers of Oxidation-Specific Epitopes in Stable Subjects with Coronary Artery Disease.D-二聚体与稳定型冠心病患者斑块特征及氧化特异性表位血浆生物标志物的相关性。
J Cardiovasc Transl Res. 2018 Jun;11(3):221-229. doi: 10.1007/s12265-018-9790-4. Epub 2018 Jan 17.
3
基于中国河北省多中心、回顾性、观察性研究的结果，制定了一种预测接受直接经皮冠状动脉介入治疗的急性 ST 段抬高型心肌梗死患者住院期间死亡率的列线图。
BMJ Open. 2022 Feb 2;12(2):e056101. doi: 10.1136/bmjopen-2021-056101.
4
D-dimer for risk stratification and antithrombotic treatment management in acute coronary syndrome patients: asystematic review and metanalysis.D-二聚体在急性冠脉综合征患者风险分层及抗栓治疗管理中的应用：一项系统评价与荟萃分析
Thromb J. 2021 Dec 18;19(1):102. doi: 10.1186/s12959-021-00354-y.
From clinical observations to molecular mechanisms and back to patients: the successful circuit of the CANTOS study.
从临床观察到分子机制，再回归患者：CANTOS研究的成功循环。
Cardiovasc Res. 2018 Jan 1;114(1):e3-e5. doi: 10.1093/cvr/cvx219.
4
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).2017年欧洲心脏病学会（ESC）ST段抬高型急性心肌梗死患者管理指南：欧洲心脏病学会（ESC）ST段抬高型急性心肌梗死患者管理工作组
Eur Heart J. 2018 Jan 7;39(2):119-177. doi: 10.1093/eurheartj/ehx393.
5
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
6
Prognostic Value of Combination of Plasma D-Dimer Concentration and Estimated Glomerular Filtration Rate in Predicting Long-Term Mortality of Patients With Stable Coronary Artery Disease.血浆 D-二聚体浓度与估算肾小球滤过率联合预测稳定性冠心病患者长期死亡率的预后价值。
Circ J. 2017 Sep 25;81(10):1506-1513. doi: 10.1253/circj.CJ-16-1272. Epub 2017 May 25.
7
D-Dimer Levels Predict Myocardial Injury in ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Imaging Study.D-二聚体水平预测ST段抬高型心肌梗死中的心肌损伤：一项心脏磁共振成像研究
PLoS One. 2016 Aug 11;11(8):e0160955. doi: 10.1371/journal.pone.0160955. eCollection 2016.
8
Long-term prognostic utility of pentraxin 3 and D-dimer as compared to high-sensitivity C-reactive protein and B-type natriuretic peptide in suspected acute coronary syndrome.与高敏C反应蛋白和B型利钠肽相比，五聚体3和D - 二聚体在疑似急性冠状动脉综合征中的长期预后效用
Eur J Prev Cardiol. 2016 Jul;23(11):1130-40. doi: 10.1177/2047487315619733. Epub 2015 Dec 3.
9
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).2015年欧洲心脏病学会（ESC）非持续性ST段抬高型急性冠脉综合征患者管理指南：欧洲心脏病学会（ESC）非持续性ST段抬高型急性冠脉综合征患者管理工作组
Eur Heart J. 2016 Jan 14;37(3):267-315. doi: 10.1093/eurheartj/ehv320. Epub 2015 Aug 29.
10
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.2014年美国心脏协会/美国心脏病学会非ST段抬高型急性冠状动脉综合征患者管理指南：美国心脏病学会/美国心脏协会实践指南工作组报告
J Am Coll Cardiol. 2014 Dec 23;64(24):e139-e228. doi: 10.1016/j.jacc.2014.09.017. Epub 2014 Sep 23.